[{"address1": "6230 Stoneridge Mall Road", "city": "Pleasanton", "state": "CA", "zip": "94588-3260", "country": "United States", "phone": "925 401 7300", "website": "https://www.10xgenomics.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.", "fullTimeEmployees": 1259, "companyOfficers": [{"maxAge": 1, "name": "Dr. Serge  Saxonov Ph.D.", "age": 47, "title": "Co-Founder, CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 925051, "exercisedValue": 1981512, "unexercisedValue": 19255640}, {"maxAge": 1, "name": "Dr. Benjamin J. Hindson Ph.D.", "age": 49, "title": "Co-Founder, President, Chief Scientific Officer & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 618324, "exercisedValue": 1497886, "unexercisedValue": 1173012}, {"maxAge": 1, "name": "Mr. Eric S. Whitaker Esq.", "age": 57, "title": "Chief Legal Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 615380, "exercisedValue": 3189201, "unexercisedValue": 3609628}, {"maxAge": 1, "name": "Mr. Adam S. Taich", "age": 48, "title": "CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Goodrich", "title": "Chief of Global Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Schnall-Levin", "title": "Founding Scientist & CTO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Wong", "title": "Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cassie  Corneau", "title": "Manager of Investor Relations & Strategic Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Port", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mennah  Moustafa", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 15.83, "open": 15.28, "dayLow": 14.88, "dayHigh": 15.65, "regularMarketPreviousClose": 15.83, "regularMarketOpen": 15.28, "regularMarketDayLow": 14.88, "regularMarketDayHigh": 15.65, "beta": 1.873, "forwardPE": -25.540983, "volume": 1422194, "regularMarketVolume": 1422194, "averageVolume": 1891865, "averageVolume10days": 1465810, "averageDailyVolume10Day": 1465810, "bid": 15.52, "ask": 15.61, "bidSize": 200, "askSize": 200, "marketCap": 1886021248, "fiftyTwoWeekLow": 12.95, "fiftyTwoWeekHigh": 51.22, "priceToSalesTrailing12Months": 2.9949064, "fiftyDayAverage": 15.1639, "twoHundredDayAverage": 20.930574, "currency": "USD", "enterpriseValue": 1573745280, "profitMargins": -0.28988, "floatShares": 104960259, "sharesOutstanding": 106998000, "sharesShort": 6171260, "sharesShortPriorMonth": 6858911, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.051, "heldPercentInsiders": 0.02161, "heldPercentInstitutions": 0.96014, "shortRatio": 3.09, "shortPercentOfFloat": 0.0668, "impliedSharesOutstanding": 121054000, "bookValue": 5.972, "priceToBook": 2.6088412, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -182551008, "trailingEps": -1.52, "forwardEps": -1.22, "enterpriseToRevenue": 2.499, "enterpriseToEbitda": -11.677, "52WeekChange": -0.6499663, "SandP52WeekChange": 0.22263205, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TXG", "underlyingSymbol": "TXG", "shortName": "10x Genomics, Inc.", "longName": "10x Genomics, Inc.", "firstTradeDateEpochUtc": 1568295000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a0172356-0b5e-3fef-869a-ffa560e26816", "messageBoardId": "finmb_223288117", "gmtOffSetMilliseconds": -18000000, "currentPrice": 15.58, "targetHighPrice": 28.0, "targetLowPrice": 14.0, "targetMeanPrice": 20.14286, "targetMedianPrice": 20.0, "recommendationMean": 2.23529, "recommendationKey": "buy", "numberOfAnalystOpinions": 14, "totalCash": 398159008, "totalCashPerShare": 3.289, "ebitda": -134768992, "totalDebt": 85876000, "quickRatio": 3.973, "currentRatio": 4.899, "totalRevenue": 629742976, "debtToEquity": 11.881, "revenuePerShare": 5.261, "returnOnAssets": -0.11372, "returnOnEquity": -0.24870001, "freeCashflow": 97398128, "operatingCashflow": 39170000, "revenueGrowth": -0.013, "grossMargins": 0.66632, "ebitdaMargins": -0.21400999, "operatingMargins": -0.27355, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]